retatrutide glp-1 gip glucagon agonist Retatrutide, a GIP, and receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Will Retatrutide Replace Tirzepatide

Single-cell, omics studies of human L-cells, which secrete GLP-1 and 2, may uncover regulatory networks controlling incretin secretion

Pre-Consultation Preparation Before Your Consultation: Gather Information: Current weight (weigh yourself that morning) Current height (measure or recall) Recent blood pressure reading (if available) List of current medications (names and doses) List of supplements and vitamins Known medication allergies Health conditions and diagnoses Prepare Your Space: Quiet, private location Good lighting (if video call) Stable internet connection Phone/computer charged Pen and paper for notes Think About Questions: Medication options and differences Expected results and timeline Side effect management Cost and payment options Follow-up schedule What happens if it doesnt work Health Questionnaire (Usually First Step) Typical Questions Youll Answer: Demographic Information: Name, date of birth, address Contact information Emergency contact Physical Measurements: Height and weight BMI (calculated automatically) Recent blood pressure Waist circumference (if known) Medical History: Current health conditions Previous surgeries Hospitalizations Chronic diseases Mental health history Medication History: Current prescription medications Over-the-counter medications Supplements and vitamins Allergies and reactions Previous weight loss medications Family History: Obesity in family Diabetes in family Heart disease in family Thyroid cancer (critical screening question) MEN 2 syndrome (critical screening question) Lifestyle Assessment: Current diet patterns Exercise habits Alcohol consumption Smoking status Sleep quality and duration Stress levels Social support Weight Loss History: Highest adult weight Lowest adult weight as adult Previous dieting attempts Previous weight loss medications Bariatric surgery (if any) What has/hasnt worked Goals and Motivation: Target weight loss amount Timeline expectations Primary motivations Barriers you anticipate Support system available Take your time with questionnaireaccuracy is important for safe prescribing

Although the "PD1and LAG3" combination therapy faced setbacks in MSS mCRC, BMS has stated that research on this combination therapy for treating other types of tumors will proceed as planned

Comprehensive quality assurance procedures include analytical verification of identity, purity assessment through high-performance liquid chromatography (HPLC), and batch-specific quality control documentation

The clinician retains sole discretion to prescribe